サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386266

遺伝性網膜疾患市場レポート：2030年までの動向、予測、競合分析

Inherited Retinal Disease Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

遺伝性網膜疾患市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

遺伝性網膜疾患の動向と予測

世界の遺伝性網膜疾患市場は、2024年から2030年までのCAGRが7.5%で、2030年までに推定55億米ドルに達すると予想されます。この市場の主な促進要因は、政府によるIRDの研究および新治療法の開発への資金提供の増加、IRDの有病率の上昇、IRDに対する人々の意識の高まりです。世界の遺伝性網膜疾患（IRD）市場の将来は、病院、専門クリニック、外来手術センター、在宅医療の各市場におけるビジネスチャンスで有望視されています。

遺伝性網膜疾患市場の洞察

Lucintelの予測では、遺伝性網膜疾患の早期診断に対する需要の高まりから、診断が予測期間中に高い成長を遂げる見込みです。

この市場において、病院は診断、治療、リハビリテーションを含む幅広いサービスを遺伝性網膜疾患患者に提供するためのリソースと専門知識の存在により、最大のセグメントであり続けるであろう。

北米はヘルスケアのインフラが整備されているため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の遺伝性網膜疾患市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の遺伝性網膜疾患市場の動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界の遺伝性網膜疾患市場
    • 診断
    • 治療
  • 疾患タイプ別の世界の遺伝性網膜疾患市場
    • 網膜色素変性症
    • シュタルガルト病
    • アクロマトプシア
    • 錐体桿体ジストロフィー
    • 脈絡膜血症
    • レバー先天性黒内障
    • 黄斑浮腫
    • その他
  • 最終用途別の世界の遺伝性網膜疾患市場
    • 病院
    • 専門クリニック
    • 外来手術センター
    • 在宅ヘルスケア
    • その他
  • 流通チャネル別の世界の遺伝性網膜疾患市場
    • 小売販売
    • 直接入札

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の遺伝性網膜疾患市場
  • 北米の遺伝性網膜疾患市場
  • 欧州の遺伝性網膜疾患市場
  • アジア太平洋の遺伝性網膜疾患市場
  • その他地域遺伝性網膜疾患市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の遺伝性網膜疾患市場の成長機会
    • 疾患タイプ別の世界の遺伝性網膜疾患市場の成長機会
    • 最終用途別の世界の遺伝性網膜疾患市場の成長機会
    • 流通チャネル別の世界の遺伝性網膜疾患市場の成長機会
    • 地域別の世界の遺伝性網膜疾患市場の成長機会
  • 世界の遺伝性網膜疾患市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の遺伝性網膜疾患市場の能力拡大
    • 世界の遺伝性網膜疾患市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos
目次

Inherited Retinal Disease Trends and Forecast

The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

A more than 150-page report is developed to help in your business decisions.

Inherited Retinal Disease by Segment

The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.

Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Therapy

Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Retinitis Pigmentosa
  • Stargardt'S Disease
  • Achromatopsia
  • Cone-Rod Dystrophy
  • Choroideremia
  • Leber Congenital Amaurosis
  • Macular Edema
  • Others

Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Home Healthcare
  • Others

Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Sales
  • Direct Tender

Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Inherited Retinal Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos

Inherited Retinal Disease Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.

North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Features of the Global Inherited Retinal Disease Market

Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the inherited retinal disease market size?

Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for inherited retinal disease market?

Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?

Answer: The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

Q4. What are the major segments for inherited retinal disease market?

Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key inherited retinal disease market companies?

Answer: Some of the key inherited retinal disease companies are as follows:

  • Spark Therapeutics
  • Novartis
  • Okuvision
  • Nidek
  • Invitae Corporation
  • Zeiss
  • Optos

Q6. Which inherited retinal disease market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardt's disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inherited Retinal Disease Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Inherited Retinal Disease Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Inherited Retinal Disease Market by Type
    • 3.3.1: Diagnosis
    • 3.3.2: Therapy
  • 3.4: Global Inherited Retinal Disease Market by Disease Type
    • 3.4.1: Retinitis Pigmentosa
    • 3.4.2: Stargardt's Disease
    • 3.4.3: Achromatopsia
    • 3.4.4: Cone-Rod Dystrophy
    • 3.4.5: Choroideremia
    • 3.4.6: Leber Congenital Amaurosis
    • 3.4.7: Macular Edema
    • 3.4.8: Others
  • 3.5: Global Inherited Retinal Disease Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Home Healthcare
    • 3.5.5: Others
  • 3.6: Global Inherited Retinal Disease Market by Distribution Channel
    • 3.6.1: Retail Sales
    • 3.6.2: Direct Tender

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Inherited Retinal Disease Market by Region
  • 4.2: North American Inherited Retinal Disease Market
    • 4.2.2: North American Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.3: European Inherited Retinal Disease Market
    • 4.3.1: European Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.3.2: European Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.4: APAC Inherited Retinal Disease Market
    • 4.4.1: APAC Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.4.2: APAC Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
  • 4.5: ROW Inherited Retinal Disease Market
    • 4.5.1: ROW Inherited Retinal Disease Market by Type: Diagnosis and Therapy
    • 4.5.2: ROW Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Inherited Retinal Disease Market by Type
    • 6.1.2: Growth Opportunities for the Global Inherited Retinal Disease Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Inherited Retinal Disease Market by End Use
    • 6.1.4: Growth Opportunities for the Global Inherited Retinal Disease Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Inherited Retinal Disease Market by Region
  • 6.2: Emerging Trends in the Global Inherited Retinal Disease Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Inherited Retinal Disease Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inherited Retinal Disease Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Spark Therapeutics
  • 7.2: Novartis
  • 7.3: Okuvision
  • 7.4: Nidek
  • 7.5: Invitae Corporation
  • 7.6: Zeiss
  • 7.7: Optos